Potential drug-drug interactions among patients with schizophrenia spectrum disorders: prevalence, association with risk factors, and replicate analysis in

HIGHLIGHTS

• who: Cvetka Bau010dar Bole and collaborators from the Psychiatric Hospital Idrija, Idrija, Slovenia Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia have published the research work: Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in, in the Journal: Medicina 2023, 59, x FOR PEER REVIEW of /2023/
• what: The study showed that more than half of the patients received at least one combination that should be avoided. This study is the follow-up analysis of the cohort of patients with SSDs described in the previous . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.